BOSTON, March 10, 2022 – International law firm Proskauer announced today that it advised Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, on the closing of its thirteenth fund.
The fund was oversubscribed and closed at its hard cap of $450 million in commitments. Through its latest fund, Atlas Venture will continue to work alongside entrepreneurs to create and invest in biotech companies aimed at delivering impactful medicines to patients.
The Proskauer team was led by partner Howard Beber and associates Alexia Boyarsky, Coco H. Xiao and Victoria Byler (Private Funds); partner Scott Jones, senior counsel Adam Scoll and associate Emily Cummins (Tax).
About Proskauer
We are 800+ lawyers serving clients from 12 offices located in the leading financial and business centers in the Americas, Europe and Asia. The world’s leading organizations, companies and corporations choose us to be their representatives in their most critical situations. But more, they consider Proskauer a strategic partner to drive their business forward. We work with asset managers, major sports leagues, Fortune 500 companies, entertainment industry legends and other industry-redefining companies.
Proskauer offers a full suite of services for the investment management industry, with a market-leading global team dedicated solely to advising hedge fund, private equity and other asset managers, investment funds, financial institutions and institutional investors across all asset classes. The cross border team of over 180 lawyers is based in the U.S., UK, Asia and Latin America and includes specialists in tax, ERISA, regulation, financial services, capital markets, M&A, employment, insurance, fund finance, litigation and risk management who understand the unique technical and commercial issues relevant to investment managers.